The FDA has now resolved the shortages of Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs, which could spell the ...

Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration ...

The U.S. Food and Drug Administration approved Mirum Pharmaceuticals' genetic disorder drug on Friday, making it the first ...

Staff units evaluating high-tech surgical robots and insulin-delivery systems were gutted by Trump layoffs even though ...

Ozempic and Wegovy, the widely popular forms of semaglutide sold to treat diabetes and obesity, have officially been removed ...

Compounding pharmacies producing cheaper semaglutide products have been given notice they will soon have to stop, as the drug ...

United Natural Trading Inc. issued a recall for Wegmans organic dry roasted salted almonds in January because they were ...

The U.S. Food and Drug Administration said on Friday there was no longer a shortage of Novo Nordisk's popular weight-loss and ...

A batch of recalled Wegmans nuts has been issued a Class II risk classification by the U.S. Food and Drug Administration ( ...

Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity ...

The FDA is investigating a deadly listeria outbreak linked to Lyons ReadyCare and Sysco Imperial frozen shakes, resulting in ...

More than 15.5 million Americans have tried weight loss injectables, but risks are rising with the proliferation of ...